tirzepatide weight loss wexford (zepbound) 12-Week Program at Bethany Clinic, NJ Tirzepatide Weight Loss Injections Near
Description
Theres subcutaneous (sits-under-the-skin) fat, and visceral fat, which coats the abdominal cavity and major organs
However, the SURMOUNT-5 trial compared tirzepatide to semaglutide 2.4mg (a more potent GLP-1 agonist than liraglutide), and tirzepatide still showed superior weight loss: 20.2% vs 13.7% at 72 weeks
This distinction has significant implications for weight loss, metabolic health, and treatment selection
This professional step ensures treatment begins on a solid foundation and reduces unnecessary risks
We will explore what you need to know about GLP-1s
